FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma

Trials

MonumenTAL-1, MonumenTAL-1

Drug

Talvey (talquetamab-tgvs) · Anti-GPRC5D-CD3 bispecific antibody

Condition

Plasma cell